[1]
Raut, S., Gujar, R.K., Ali, M. and Bhopalwala Ali, F. 2023. UTILITY OF HBME1 IMMUNOSTAIN IN DIFFERENTIATING REACTIVE MESOTHELIAL CELLS LESIONS FROM MALIGNANT EPITHELIAL CELLS LESIONS IN SEROUS EFFUSIONS. Asian Journal of Pharmaceutical and Clinical Research. 16, 6 (Jun. 2023), 53–55. DOI:https://doi.org/10.22159/ajpcr.2023.v16i6.47279.